Improving Functional Ability in Chronic TBI With Intensive Rehabilitation Robotic Gait Training
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03438409|
Recruitment Status : Recruiting
First Posted : February 19, 2018
Last Update Posted : February 19, 2018
|Condition or disease||Intervention/treatment||Phase|
|TBI (Traumatic Brain Injury)||Other: Robotic gait training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improving Functional Ability in Chronic TBI With Intensive Rehabilitation Robotic Gait Training|
|Actual Study Start Date :||July 1, 2017|
|Estimated Primary Completion Date :||June 30, 2019|
|Estimated Study Completion Date :||June 30, 2019|
Experimental: Single Arm Study
This study has a single arm with repeated baseline measures. This arm will complete the robotic gait training.
Other: Robotic gait training
Robotic gait training
- Change in Functional Gait Outcomes [ Time Frame: Change from baseline gait speed to post-test up to 6 weeks following the intervention. ]Gait speed will be assessed using a gait mat.
- Change in Endurance [ Time Frame: Change from baseline distance covered to post-test up to 6 weeks following the intervention. ]Endurance will be assessed using the 6-minute walk test.
- Change in balance [ Time Frame: Change from baseline balance to post-test up to 6 weeks following the intervention. ]Balance will be assessed using the Berg Balance Scale.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03438409
|Contact: Crystal Massie, PhD, OTRemail@example.com|
|United States, Indiana|
|Indianapolis, Indiana, United States, 46202|
|Contact: Crystal Massie, PhD, OTR 317-278-9617 firstname.lastname@example.org|